paclitaxel has been researched along with Lymphoma, B-Cell in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, D; Hu, Y; Ma, X; Sheng, R; Wang, C; Wei, J | 1 |
| Butterfield, JT; Knauer, DJ; Markovic, SN; Nevala, WK; Sutor, SL | 1 |
| Dang, NH; Fanale, M; Fayad, L; Feng, L; Fowler, N; Hagemeister, FB; Loyer, E; McLaughlin, P; Nastoupil, L; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, J; Samaniego, F; Westin, JR; Younes, A | 1 |
| Albeck, M; Danoch, H; Kalechman, Y; Longo, DL; Sredni, B | 1 |
| Bonavida, B; Emmanouilides, C; Jazirehi, AR | 1 |
| Allman, R; Errington, RJ; Smith, PJ | 1 |
| Abacioğlu, U; Berrak, SG; Canpolat, C; Dağli, T; Iskit, S; Türkkan, E | 1 |
| Lee, NS; Pluznik, DH; Sawada, T | 1 |
| Basu, A; Croce, CM; Haldar, S | 1 |
| Hoffman, M; Lesser, M; Rai, K; Xu, JC | 1 |
| Beyaert, R; Daniel, PT; Dörken, B; Essmann, F; Prokop, A; Schmelz, K; Schulze-Osthoff, K; Wieder, T | 1 |
| He, K; Xu, L; Zhou, X | 2 |
1 trial(s) available for paclitaxel and Lymphoma, B-Cell
| Article | Year |
|---|---|
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Paclitaxel; Recurrence; Rituximab; Salvage Therapy; Survival Analysis; Topotecan; Treatment Outcome; Young Adult | 2014 |
12 other study(ies) available for paclitaxel and Lymphoma, B-Cell
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies.
Topics: Administration, Oral; Animals; Antineoplastic Agents; B-Lymphocytes; Benzothiadiazines; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Drug Design; Lymphoma, B-Cell; Molecular Docking Simulation; Protein Kinase Inhibitors; Rats, Sprague-Dawley | 2019 |
Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20
Topics: Animals; Antigens, CD20; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Humans; Lymphoma, B-Cell; Mice; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Rituximab; Treatment Outcome | 2017 |
Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane-Induced Death by AS101 via Inhibition of the VLA-4-IL10-Survivin Axis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Ethylenes; Humans; Inhibitor of Apoptosis Proteins; Integrin alpha4beta1; Interleukin-10; Lymphoma, B-Cell; Lymphoma, T-Cell; Mice; Neoplasm Transplantation; Paclitaxel; Repressor Proteins; Signal Transduction; Survivin | 2015 |
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lymphoma, B-Cell; Paclitaxel; Rituximab; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2002 |
Delayed expression of apoptosis in human lymphoma cells undergoing low-dose taxol-induced mitotic stress.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphoma, B-Cell; Lymphoma, Follicular; Mitosis; Paclitaxel; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Partial intestinal obstruction due to childhood refractory hon-Hodgkin's lymphoma, successfully treated with taxol.
Topics: Antineoplastic Agents, Phytogenic; Child; Combined Modality Therapy; Humans; Ileal Neoplasms; Intestinal Obstruction; Lymphoma, B-Cell; Male; Paclitaxel; Radiography; Treatment Outcome | 2003 |
Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA.
Topics: Animals; Base Sequence; Cell Nucleus; Dose-Response Relationship, Drug; Down-Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Interleukin-4; Lipopolysaccharides; Lymphoma, B-Cell; Mice; Molecular Sequence Data; Paclitaxel; Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 1994 |
Bcl2 is the guardian of microtubule integrity.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Chronic Disease; Docetaxel; G2 Phase; Humans; Leukemia; Lymphoma, B-Cell; Male; Microtubules; Paclitaxel; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Tumor Cells, Cultured | 1997 |
Cytotoxicity of 2-chlorodeoxadenosine (cladribine, 2-cdA) in combination with other chemotherapy drugs against two lymphoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cisplatin; Cladribine; Drug Screening Assays, Antitumor; Etoposide; Humans; Lymphoma, B-Cell; Paclitaxel; Tumor Cells, Cultured | 1999 |
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Topics: Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Marrow; Carrier Proteins; Caspase 3; Caspase 8; Caspase 9; Caspases; Child; Epirubicin; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Humans; Immunoblotting; Lymphoma, B-Cell; Membrane Glycoproteins; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transfection; Tumor Cells, Cultured | 2001 |
[The role of bcl-2 gene family in taxol-mediated apoptosis in BJAB B cell lymphoma cell line].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Dose-Response Relationship, Drug; Gene Expression Regulation, Leukemic; Genes, bcl-2; Humans; Lymphoma, B-Cell; Paclitaxel; Tumor Cells, Cultured | 2000 |
[The effects of taxol on different types of lymphoma cell lines].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; DNA Fragmentation; Flow Cytometry; Humans; Jurkat Cells; Lymphoma, B-Cell; Paclitaxel; Tumor Cells, Cultured | 2000 |